Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD1981 in Moderate to Severe COPD – 4-week Phase IIa Trial
2008-000340-13Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing AZD1981 with Placebo (2 arms). Primary endpoint: Change in pre-bronchodilator FEV1 from baseline to end of treatment. Started Mar 2008; status: completed.
02
Drugs
timapiprant
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2008-000340-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000340-13.